Correlation Between Edgewise Therapeutics and Citius Oncology,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Citius Oncology, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Citius Oncology, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Citius Oncology,, you can compare the effects of market volatilities on Edgewise Therapeutics and Citius Oncology, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Citius Oncology,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Citius Oncology,.

Diversification Opportunities for Edgewise Therapeutics and Citius Oncology,

-0.81
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Edgewise and Citius is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Citius Oncology, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Citius Oncology, and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Citius Oncology,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Citius Oncology, has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Citius Oncology, go up and down completely randomly.

Pair Corralation between Edgewise Therapeutics and Citius Oncology,

Given the investment horizon of 90 days Edgewise Therapeutics is expected to generate 0.42 times more return on investment than Citius Oncology,. However, Edgewise Therapeutics is 2.39 times less risky than Citius Oncology,. It trades about 0.07 of its potential returns per unit of risk. Citius Oncology, is currently generating about -0.22 per unit of risk. If you would invest  883.00  in Edgewise Therapeutics on August 26, 2024 and sell it today you would earn a total of  2,337  from holding Edgewise Therapeutics or generate 264.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy15.09%
ValuesDaily Returns

Edgewise Therapeutics  vs.  Citius Oncology,

 Performance 
       Timeline  
Edgewise Therapeutics 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Edgewise Therapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Edgewise Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Citius Oncology, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Citius Oncology, has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Edgewise Therapeutics and Citius Oncology, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Edgewise Therapeutics and Citius Oncology,

The main advantage of trading using opposite Edgewise Therapeutics and Citius Oncology, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Citius Oncology, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Citius Oncology, will offset losses from the drop in Citius Oncology,'s long position.
The idea behind Edgewise Therapeutics and Citius Oncology, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments